Harte Hanks (HHS) Payables (2016 - 2025)
Harte Hanks (HHS) has disclosed Payables for 16 consecutive years, with $18.1 million as the latest value for Q3 2025.
- On a quarterly basis, Payables fell 13.3% to $18.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $18.1 million, a 13.3% decrease, with the full-year FY2024 number at $21.8 million, down 5.8% from a year prior.
- Payables was $18.1 million for Q3 2025 at Harte Hanks, down from $18.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $23.2 million in Q4 2023 to a low of $16.0 million in Q1 2024.
- A 5-year average of $19.1 million and a median of $18.6 million in 2025 define the central range for Payables.
- Peak YoY movement for Payables: surged 39.26% in 2022, then decreased 20.04% in 2024.
- Harte Hanks' Payables stood at $16.1 million in 2021, then surged by 39.26% to $22.5 million in 2022, then increased by 3.16% to $23.2 million in 2023, then decreased by 5.8% to $21.8 million in 2024, then dropped by 17.08% to $18.1 million in 2025.
- Per Business Quant, the three most recent readings for HHS's Payables are $18.1 million (Q3 2025), $18.6 million (Q2 2025), and $22.0 million (Q1 2025).